109 related articles for article (PubMed ID: 23578092)
1. Interaction of Mycobacterium tuberculosis cell wall components with the human natural killer cell receptors NKp44 and Toll-like receptor 2.
Esin S; Counoupas C; Aulicino A; Brancatisano FL; Maisetta G; Bottai D; Di Luca M; Florio W; Campa M; Batoni G
Scand J Immunol; 2013 Jun; 77(6):460-9. PubMed ID: 23578092
[TBL] [Abstract][Full Text] [Related]
2. NKp44/HLA-DP-dependent regulation of CD8 effector T cells by NK cells.
Padoan B; Casar C; Krause J; Schultheiss C; Baumdick ME; Niehrs A; Zecher BF; Pujantell M; Yuki Y; Martin M; Remmerswaal EBM; Dekker T; van der Bom-Baylon ND; Noble JA; Carrington M; Bemelman FJ; van Lier RAW; Binder M; Gagliani N; Bunders MJ; Altfeld M
Cell Rep; 2024 Apr; 43(4):114089. PubMed ID: 38615318
[TBL] [Abstract][Full Text] [Related]
3. A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44.
Niehrs A; Garcia-Beltran WF; Norman PJ; Watson GM; Hölzemer A; Chapel A; Richert L; Pommerening-Röser A; Körner C; Ozawa M; Martrus G; Rossjohn J; Lee JH; Berry R; Carrington M; Altfeld M
Nat Immunol; 2019 Sep; 20(9):1129-1137. PubMed ID: 31358998
[TBL] [Abstract][Full Text] [Related]
4. TLR2 on CD4+ and CD8+ T cells promotes control of Mycobacterium tuberculosis infection.
Reba SM; Li Q; Onwuzulike S; Nagy N; Fletcher S; Parker K; Shaw RJ; Umphred-Wilson K; Shukla S; Harding CV; Boom WH; Rojas RE
Eur J Immunol; 2024 May; 54(5):e2350715. PubMed ID: 38446066
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of antitumor natural killer cell activation by orally administered Spirulina extract in mice.
Akao Y; Ebihara T; Masuda H; Saeki Y; Akazawa T; Hazeki K; Hazeki O; Matsumoto M; Seya T
Cancer Sci; 2009 Aug; 100(8):1494-501. PubMed ID: 19432881
[TBL] [Abstract][Full Text] [Related]
6. [Research progress on Toll-like receptor 2 (TLR2) with Mycobacterium tuberculosis infection].
Chen R; Wang X; Ma F; Zhou X; Wu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Apr; 40(4):367-372. PubMed ID: 38710520
[TBL] [Abstract][Full Text] [Related]
7. GanedenBC30 cell wall and metabolites: anti-inflammatory and immune modulating effects in vitro.
Jensen GS; Benson KF; Carter SG; Endres JR
BMC Immunol; 2010 Mar; 11():15. PubMed ID: 20331905
[TBL] [Abstract][Full Text] [Related]
8. Gintonin upregulates cytokine production and expression of NKp30, NKp44 and NKp44 related to natural killer cell activity on immunosuppressive rat.
Chen B; Vijayakumar A; Park C; Choi U; Nah SY; Kim JH
J Ginseng Res; 2024 May; 48(3):341-345. PubMed ID: 38707639
[TBL] [Abstract][Full Text] [Related]
9. The Mycobacterial Cell Wall--Peptidoglycan and Arabinogalactan.
Alderwick LJ; Harrison J; Lloyd GS; Birch HL
Cold Spring Harb Perspect Med; 2015 Mar; 5(8):a021113. PubMed ID: 25818664
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells: a coherent model for their functional role in Mycobacterium tuberculosis infection.
Esin S; Batoni G
J Innate Immun; 2015; 7(1):11-24. PubMed ID: 25196698
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium tuberculosis keto-mycolic acid and macrophage nuclear receptor TR4 modulate foamy biogenesis in granulomas: a case of a heterologous and noncanonical ligand-receptor pair.
Dkhar HK; Nanduri R; Mahajan S; Dave S; Saini A; Somavarapu AK; Arora A; Parkesh R; Thakur KG; Mayilraj S; Gupta P
J Immunol; 2014 Jul; 193(1):295-305. PubMed ID: 24907344
[TBL] [Abstract][Full Text] [Related]
12. Host-pathogen interactions during Mycobacterium tuberculosis infections.
Stanley SA; Cox JS
Curr Top Microbiol Immunol; 2013; 374():211-41. PubMed ID: 23881288
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of Glutathione.
Allen M; Bailey C; Cahatol I; Dodge L; Yim J; Kassissa C; Luong J; Kasko S; Pandya S; Venketaraman V
Front Immunol; 2015; 6():508. PubMed ID: 26500648
[TBL] [Abstract][Full Text] [Related]
14. Attenuated Cytokine-Induced Memory-Like Natural Killer Cell Responses to
Liang C; Li S; Yuan J; Song Y; Ren W; Wang W; Shang Y; Tang S; Pang Y
Infect Drug Resist; 2023; 16():2349-2364. PubMed ID: 37101462
[TBL] [Abstract][Full Text] [Related]
15. [Expert consensus on immunotherapy for tuberculosis (2022 edition)].
Chinese Society of Tuberculosis, Chinese Medical Association
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jul; 45(7):651-666. PubMed ID: 35768373
[TBL] [Abstract][Full Text] [Related]
16. Immunology of
Sia JK; Rengarajan J
Microbiol Spectr; 2019 Jul; 7(4):. PubMed ID: 31298204
[TBL] [Abstract][Full Text] [Related]
17. Innate immunity in tuberculosis: host defense vs pathogen evasion.
Liu CH; Liu H; Ge B
Cell Mol Immunol; 2017 Dec; 14(12):963-975. PubMed ID: 28890547
[TBL] [Abstract][Full Text] [Related]
18. The interaction of macrophages and CD8 T cells in bronchoalveolar lavage fluid is associated with latent tuberculosis infection.
Yang Q; Qi F; Ye T; Li J; Xu G; He X; Deng G; Zhang P; Liao M; Qiao K; Zhang Z
Emerg Microbes Infect; 2023 Dec; 12(2):2239940. PubMed ID: 37470432
[TBL] [Abstract][Full Text] [Related]
19. The immune landscape in tuberculosis reveals populations linked to disease and latency.
Esaulova E; Das S; Singh DK; Choreño-Parra JA; Swain A; Arthur L; Rangel-Moreno J; Ahmed M; Singh B; Gupta A; Fernández-López LA; de la Luz Garcia-Hernandez M; Bucsan A; Moodley C; Mehra S; García-Latorre E; Zuniga J; Atkinson J; Kaushal D; Artyomov MN; Khader SA
Cell Host Microbe; 2021 Feb; 29(2):165-178.e8. PubMed ID: 33340449
[TBL] [Abstract][Full Text] [Related]
20. Natural and trained innate immunity against Mycobacterium tuberculosis.
Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
